Table 10.

Difference in means between treatment and control groups for TG at final follow-up

Author	Sample size (treatment group vs. control group)	Difference	95% CI
Cabral et al. [57]	32 (14 vs. 18)	− 1.72 mmol/L*	− 3.51 to 0.07
Caraccio et al. [58]	49 (24 vs. 25)	− 0.10 mmol/L*	− 0.46 to 0.26
Duman et al. [60]	39 (20 vs. 19)	− 1.94 mmol/L*	− 3.65 to − 0.24
Iqbal et al. [62]	64 (32 vs. 32)	− 0.10 mmol/L*	− 0.52 to 0.32
Liu et al. [64]	119 (60 vs. 59)	− 0.08 mmol/L**	− 0.26 to 0.10
Mikhail et al. [66]	120 (60 vs. 60)	− 0.11 mmol/L*	− 0.31 to 0.09
Monzani et al. [68]	45 (23 vs. 22)	− 0.81 mmol/L*	− 2.22 to 0.60
Nagasaki et al. [69]	95 (48 vs. 47)	0.12 mmol/L**	− 0.17 to 0.41
Teixeira et al. [74, 75]	26 (11 vs. 15)	− 0.98 mmol/L*	− 3.52 to 1.55

*Value is the difference in mean scores at final follow-up between treatment and control groups

**Value is the difference in mean variation scores from baseline to follow-up between treatment and control group